MCMedicalCodingSoftware
C9046

C9046: Cocaine hydrochloride nasal solution (goprelto), 1 mg

HCPCSTerminatedBETOS O1E

C9046 is a HCPCS Level II code for cocaine hydrochloride nasal solution (goprelto), 1 mg. It belongs to the Outpatient Prospective Payment System section. It was terminated on September 30, 2026 and is not valid on new claims.

This code has been terminated

CMS terminated C9046 on September 30, 2026. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Medically Unlikely Edits: units per day

The most units of C9046 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
160 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
outpatient
160 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for C9046

Long descriptor
Cocaine hydrochloride nasal solution (goprelto), 1 mg

The official wording. This is what the code means.

Short descriptor
Cocaine hcl nasal (goprelto)

CMS's 28-character form, which is what shows up on a remittance advice.

Added
April 1, 2019

When CMS introduced the code.

Terminated
September 30, 2026

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
53: Other

Statute.

Codes adjacent to C9046

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If C9046 is not quite right, the correct code is very often within a few positions of it.

  • C9038Injection, mogamulizumab-kpkc, 1 mgterminated
  • C9039Injection, plazomicin, 5 mgterminated
  • C9040Injection, fremanezumab-vfrm, 1mgterminated
  • C9041Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mgterminated
  • C9042Injection, bendamustine hcl (belrapzo), 1 mgterminated
  • C9043Injection, levoleucovorin, 1 mgterminated
  • C9044Injection, cemiplimab-rwlc, 1 mgterminated
  • C9045Injection, moxetumomab pasudotox-tdfk, 0.01 mgterminated
  • C9047Injection, caplacizumab-yhdp, 1 mg
  • C9048Dexamethasone, lacrimal ophthalmic insert, 0.1 mgterminated
  • C9049Injection, tagraxofusp-erzs, 10 mcgterminated
  • C9050Injection, emapalumab-lzsg, 1 mgterminated
  • C9051Injection, omadacycline, 1 mgterminated
  • C9052Injection, ravulizumab-cwvz, 10 mgterminated
  • C9053Injection, crizanlizumab-tmca, 1 mgterminated
  • C9054Injection, lefamulin (xenleta), 1 mgterminated
HCPCS Level II2026Q4-Oct· effective October 1, 2026